Clinical Trial Update: Combined Ketamine and Midazolam for Generalized Convulsive Status Epilepticus [Phase 2, Phase 3]

View source ↗

Summary

A phase 2/3 clinical trial evaluating a combined ketamine and midazolam regimen for Generalized Convulsive Status Epilepticus has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Generalized Convulsive Status Epilepticus

Drugs mentioned

• Ketamine (ketamine)
• Midazolam (Midazolam)

Snippet

Sponsor: Sohag University | Conditions: Generalized Convulsive Status Epilepticus | Phase 2, Phase 3 | Status: COMPLETED